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364 Abstract
65
66 Background: Isolated, subtle neurological abnormalities (ISNA) are commonly seen in aging, and 
67 have been related to cerebral Small Vessel Disease (SVD) and subcortical atrophy in neurologically 
68 and cognitively healthy aging subjects.
69
70 Objective: To investigate the frequency of ISNA in different MCI types, and to evaluate for each 
71 MCI type  the cross-sectional relation between ISNA and white matter hyperintensities (WMH), 
72 lacunes, caudate atrophy, and ventricular enlargement.
73
74 Methods: 1,250 subjects with different MCI types were included in the analysis, and  underwent 
75 brain MRI. WMH were assessed through two visual rating scales. Lacunes were also rated. Atrophy 
76 of the caudate nuclei and ventricular enlargement were assessed through the bicaudate ratio (BCr) 
77 and the lateral ventricles to brain ratio (LVBr), respectively. Apolipoprotein E (APOE) genotypes 
78 were also assessed. The routine neurological examination was used to evaluate ISNA that were 
79 clustered  as central-based signs, cerebellar-based signs, and primitive reflexes. The items of Part-III 
80 of the Unified Parkinson’s Disease Rating Scale were used to evaluate ISNA that were clustered as 
81 mild parkinsonian signs.  Associations of  ISNA with imaging findings was determined through 
82 logistic regression analysis. 
83
84 Results: The ISNA increase with the age, are present in all MCI types, particularly in those  
85 multiple domains, and carrying the APOE ε4 allele, and are associated with WMH, lacunes, BCr, 
86 and LVBr.
87
88 Conclusion: This study demonstrates that cortical and subcortical vascular and atrophic processes 
89 contribute to ISNA. Long prospective population-based studies are needed to disentangle the role of 
90 ISNA in the conversion from MCI  to dementia.
91
92
93
94
95
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5123 INTRODUCTION
124
125
126           Mild cognitive impairment (MCI) is a term that refers to a condition in which an essentially spared 
127 global cognition, and normal or slightly impaired activities of daily living coexist with a mild decline of 
128 cognitive functions greater than that expected for age and education.1,2  Four MCI phenotypes have been 
129 recognized2 as follows: amnestic MCI single domain (a-MCI), amnestic MCI multiple domain (a-
130 MCImd), nonamnestic MCI single domain (na-MCI), and nonamnestic MCI multiple domain (na-
131 MCImd). Extracellular deposition of β-amyloid (Aβ) peptide, intracellular deposition of hyper-
132 phosphorilated tau protein, and atrophy of frontal, parietal, and medial temporal cortices, i.e. 
133 neurodegeneration of  AD signature cortical regions,3 are the  key elements of  the pathophysiology of 
134 Alzheimer disease (AD),4 and MCI due to AD.5 The prevalence of Aβ positivity among subjects with 
135 MCI  increases from age 50 to 90 years from 27%  to 71%; nonamnestic MCI types have lower 
136 prevalence estimates of Aβ positivity than amnestic MCI types, but higher than subjects cognitively 
137 normal (CN), and both amnestic and nonamnestic MCI are at increased  risk for AD.6  Concerning tau, 
138 MCI and AD individuals have tau accumulation in the basal and mild-temporal, retrosplenial, posterior 
139 cingulate, and enthorinal regions greater than CN individuals Aβ positive.7 
140           The observation that  21,5% and 35% of individuals with amnestic and nonamnestic MCI types, 
141 respectively, are Aβ negative,8 has  suggested  that these individuals are not on the AD pathway, and that 
142 vascular pathology may be one of the possible  non-AD causes  of MCI. Among vascular pathology, 
143 cerebral small vessel disease (SVD) plays a pivotal role.  SVD  affects the smallest cerebral small vessels, 
144 increases throughout the lifespan,9 and contributes to the risk of MCI,10 and dementia.11 White matter 
145 hyperintensities (WMH), lacunes,  small subcortical infarcts, microbleeds, enlarged perivascular spaces, 
146 and central atrophy are the imaging markers of SVD.12 Lacunes13 and WMH14 disrupting  locally  the  
147 structural integrity of white matter induce thinning of the connected cortical regions through Wallerian 
148 degeneration. Lacunes are associated with widespread cortical thinning, atrophy in multiple subcortical 
149 structures, and ventricular enlargement.15 In subjects with MCI, expansion of the lateral ventricles is 
150 associated with atrophy of frontal, parietal, and  temporal regions affected by AD.16 Furthermore, age per 
151 se is associated with atrophy of the cerebellum, striatum, and prefrontal, parietal, and temporal 
152 association cortices.17 The pattern of  cortical atrophy induced by severe WMH overlaps substantially 
153 with the patterns of age-related cortical atrophy and of AD-related cortical atrophy.18 Since cortical 
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6154 atrophy induced by WMH drives cognitive decline,19 age and SVD may contribute to the onset of 
155 cognitive decline through the overlapping atrophy of cortical regions vulnerable to AD pathology. 
156 Cerebral SVD, Aβ, tau, and atrophic changes fragmenting over time brain networks into 
157 disconnected parts not only contribute to cognitive decline, but also contribute to the presentation of a 
158 wide range of neurological signs. We have shown that neurologically and cognitively  healthy (NCH) 
159 aging subjects frequently present at the routine neurological examination isolated, subtle, neurological 
160 abnormalities (ISNA) which do not have any immediate diagnostic relevance, cannot be attributed to any 
161 definite, overt neurological disease, are associated with atrophy of the caudate nuclei, and with parietal 
162 WMH and lacunes, and probably constitute a red flag for future cognitive decline given that they show 
163 poor performance in test evaluating  global cognition, executive function, and language.20 Past reports on 
164 neurological signs in MCI have primarily focused on extrapyramidal features,21,22 while reports on signs 
165 others than extrapyramidal are sparse. Therefore, the aims of our study are: 1) to investigate  the 
166 prevalence of  ISNA  in  the 4 MCI types; 2) to verify whether in the individual MCI types  the 
167 probability of having  ISNA is differently associated with the topographical location of WMH and  
168 lacunes, periventricular WMH (WMH-PV), APOE ε4 allele, and  with two linear measures of  central 
169 atrophy,12  i.e. the bicaudate ratio (BCr) as proxy of subcortical atrophy, and the lateral ventricles to brain  
170 ratio (LVBr) as proxy of  global brain atrophy.  In the present paper, the terms  “adult”, “elderly”, “old”, 
171 and “oldest-old” will be used  to indicate  people aged 45-64, 65-74, 75-84, and >85 years respectively.
172
173
174 METHODS
175 Participants
176         Data were used from the Cognitive Impairment through Aging (CogItA) study, a hospital-based 
177 prospective study focused on normal and pathological aging in middle-aged and older individuals 
178 launched in January, 2000. CogItA’s participants were outpatients self-referred or referred by general 
179 practitioners for neurological and/or cognitive screenings to the clinics of the Department of Neurology 
180 and Cognitive Disorders of the teaching Hospital (AOUP “P.Giaccone”) of the School of Medicine of the 
181 University of Palermo, Italy. Details of the inclusion and exclusion criteria of the CogItA study have been 
182 reported elsewhere.20 Informed consent was obtained from all participants and relatives. The study was 
183 approved by the University Hospital ethics committee, and complies with  the declaration of Helsinki.
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7184          According to the published criteria,1,2 CogItA participants with preserved global cognition at the 
185 Mini-Mental State examination (MMSE score ≥ 23,74),23 subjective cognitive concerns, objective 
186 impairment in one or more cognitive domains, Clinical Dementia Rating (CDR) = 0.5),24 no impaired or 
187 minimally impaired functional status on the activities of daily living (ADL)25 and the instrumental 
188 activities of daily living (IADL) 26 scales, and no dementia were classified as MCI and categorized as a-
189 MCI, a-MCImd, na-MCI, and  na-MCImd. MCI subjects included in the present paper were stroke-free 
190 first ever diagnosed cases (n=1,250) aged 45-95 years (mean age = 70,52 ± 9,41 years), who remained in 
191 the MCI status for at least 3 years (mean follow-up = 64,98 ± 28,94 months). During this period, some of 
192 these subjects changed their MCI typology, but in the present paper first-ever MCI diagnoses were 
193 considered. Subjects who during the follow-up  reverted to normal cognition, or converted to dementias 
194 different from AD and Vascular Dementia (VaD) were not considered.   
195
196 Baseline Clinical Assessment
197           Participants to the present study underwent an extensive assessment of variables such as 
198 demographics, medical history, laboratory tests, neurological, and functional examinations, cognitive 
199 testing, carotid ultrasonography, and brain magnetic resonance imaging (MRI). Many vascular risk 
200 factors (VRF) and  vascular diseases (VD) were considered and assessed as reported elsewhere.20,29 Since 
201 multiple VRF and VD often coexist, we created the VRF and VD summary scores indicating for each 
202 participant the sum of the individual VRF and VD that were concurrently present. APOE genotypes were 
203 determined by using standard methods.30 Participants with at  least 1 APOE ε4 allele were classified as 
204 APOE ε4 carriers.
205
206 Assessment of  ISNA 
207         All participants underwent a standardised neurological examination reflecting that routinely 
208 performed in the clinical practice. Subjects presenting at baseline or during follow-up meaningful 
209 neurological signs such as visual field defects, language deficits, cranial nerves deficits, hemimotor and 
210 hemisensory dysfunction, brachial or crural weakness, brachial or crural sensory dysfunction, Babinski 
211 sign, spastic rigidity, and hemiplegic gait were excluded. The ISNA evaluated were: 1) mild dysphagia, 2)  
212 slurred speech,  3) central facial weakness, 4) mixed rigidity, i.e. a condition in which spastic and plastic 
213 rigidity coexist; 5) hyperreflexia (bilateral increased deep tendon reflexes), 6) reflex asymmetry, 7) 
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8214 tremor (resting tremor, and postural/kinetic tremor), 8) plastic rigidity,  9) bradykinesia,  10) 
215 gait/balance/axial dysfunction, 11) dysmetria, 12)  atactic type gait  defined as a gait pattern broadly 
216 indicative of cerebellar involvement, and 13) primitive reflexes (PR) i.e. glabellar tap, snout, 
217 palmomental, grasping, and sucking reflexes.31,32 To evaluate tremor, rigidity, bradykinesia, and 
218 gait/balance/axial dysfunction, collectively called  Mild Parkinsonian Signs (MPS),33 the items of motor 
219 section of the Unified Parkinson’s Disease Rating Scale (UPDRS)34 were used, and were considered 
220 present when any one of the following condition was met:  (1) two or more  items with a score of 1; or (2) 
221 one item with a score ≥ 2.21 The ISNA were dichotomised as absent (score = 0) or present (score = 1), and 
222 were clustered  into four categories as following: central-based signs (Cs) (signs 1-6), Mild Parkinsonian 
223 Signs (MPS) (signs 7-10), cerebellar-based signs (CLs) (signs 11-12), and PR (signs 13). We defined the 
224 presence of  Cs, MPS, CLs, and PR as the presence of  at least  one sign within  those included  in each of 
225 these clusters. Accordingly, subjects were divided into subjects without ISNA (ISNA-), and with ISNA 
226 (ISNA+) if at least one sign within the above clusters was present. The neurological examination of each 
227 participant was always performed by two neurologists blinded to the patients  history and neuroimaging. 
228 The interrater reliability assessed over time  in  random samples showed always excellent agreement with 
229 weighted Cohen’s kappa ranging between 0.88 and 0.91 (p< 0.001).   
230  
231 Functional and Neuropsychological Assessments 
232 The functional status of participants was assessed through the ADL and the IADL scales. Cognitive 
233 functions were assessed using an extensive neuropsychological battery as reported elsewhere,20,35 
234 including the MMSE as test of global cognition, and  12   tests  to evaluate  memory, attention, executive 
235 function, language, constructional ability, and  visuospatial skill. Impaired cognitive domains were 
236 identified using a cut-off of 1,5 standard deviation (SD)2 below the Italian normative data adjusted for 
237 age-, sex-, and education.36
238
239 Carotid Ultrasonography and Imaging Assessments
240 Intimal-medial thickness (IMT), and stenosis of internal carotid arteries (SICA) were assessed as 
241 reported elsewhere.20 Participants had brain MRI  on a 1,5T scanner (GE Signa HDxt, Milwaukee, WI, 
242 USA).  Details of the image acquisition protocol have been  published previously.20  The BCr and the 
243 LVBr were calculated as reported elsewhere.20,35 WMH, and lacunes were assessed according to the 
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9244 published criteria.12 The Wahlund scale (range 0-3) 37 was used to obtain the scores of  WMH of the 
245 frontal, parieto-occipital, and temporal areas (WMH-SC), infratentorial (WMH-INF), basal ganglia 
246 (WMH-BG),  and  the WMH total score (WMH-T). To define the WMH status, a cut-off score ≥2 in at 
247 least one of the above regions was used. WMH-PV were evaluated with the Fazekas scale (range 0-3),38 
248 and a cut-off score ≥2 was used. Lacunes were assessed topographically according to the Wahlund 
249 regions used to score WMH, and categorized  as lacunes-SC,  lacunes-BG, lacunes-INF, and lacunes-T. A 
250 cut-off score ≥2 in at least one of the Wahlund regions was used to define the status of lacunes. Subjects  
251 having WMH and/or lacunes with a score ≥2 in at least one of the Wahlund scale topographical locations 
252 were categorized as SVD positive (SVD+), and those having WMH and/or lacunes with a score ≤1 were 
253 categorized as SVD negative (SVD-). 
254
255 Statistical Analysis  
256 Descriptive statistics (percentages, mean and SD, median and IQR) were used to summarise data. 
257 Continuous variables were compared between subjects ISNA- and ISNA+ by using one-way analysis of 
258 variance (ANOVA), and differences were tested with a post hoc F-test. Categorical variables were 
259 evaluated by contingency tables, and the hypotheses of independence were tested with  2 test. Logistic 
260 ridge regression models39 were used to evaluate for each MCI type the risk of having  ISNA covarying for 
261 age, sex, years of education, and the variables found significant in the univariate analysis. In general, 
262 ridge regression method is the most applied solution for addressing problems of multicollinearity.40 It 
263 implies adding a small positive constant (), i.e. the ridge parameter, to the main diagonal elements of the 
264 information matrix. The ridge parameter was selected using likelihood cross-validation.41 IMT, BCr, and 
265 LVBr values were scaled to work on percentage of increments.  All tests were two-tailed, and statistical 
266 significance was set at p ≤ 0.05.  Results are presented as odds ratios (ORs) with 95% confidence interval 
267 (95% CI). All analyses were performed using R statistical software (version 3.5.1; The R Foundation for 
268 Statistical Computing).    
269
270
271 RESULTS
272 The demographic characteristics of the MCI types are shown in Table 1.  In almost all MCI types, 
273 the majority of  subjects  were elderly followed by old, adult, and oldest-old individuals. The MCI types 
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274 single domain were more common among the adults, while those multiple domain were more common 
275 within the elderly, old, and oldest old participants. In each age class, the mean age didn’t vary 
276 significantly among the various MCI types.  Since  the oldest old subjects were few, subsequent  analysis 
277 was conducted pooling the old and oldest old classes in the class of old-oldest old.  
278 Within the sample, 175 (14.0%) subjects didn’t show any of the selected  ISNA, while 1,075 
279 (86.0%) presented at least one ISNA (Table 2). Overall, subjects ISNA- were more common among the 
280 MCI types single domain, and subjects ISNA+ were more common among those multiple domain. 
281 Primitive reflexes were the most frequent ISNA, followed by ISNA central-based, and  mild parkinsonian 
282 signs, while ISNA cerebellar-based were the rarest.  PR were exhibited by 864 subjects (69.1%) of the 
283 sample, and were more common among  the MCI types multiple domain than those single domain. In all 
284 MCI types, snout reflex was the most common PR followed by glabellar tap, and palmomental reflex, 
285 while grasping  and sucking reflexes were the rarest. Snout and palmomental reflexes were more common 
286 among the MCI types multiple domain than those single domain, while glabellar tap was more common 
287 among the amnestic MCI types than the nonamnestic types.  The mean number of PR was greater among 
288 the amnestic MCI types than the nonamnestic types. Central-based  signs were exhibited  by 645 subjects 
289 (51,6%) of the sample. Subjects with Cs were more common among the nonamnestic MCI types than the 
290 amnestic types. In all MCI types, reflex asymmetry was the most common Cs, followed by bilateral 
291 hyperreflexia, central facial weakness, mixed rigidity, slurred speech, and dysphagia. Reflex asymmetry, 
292 bilateral hyperreflexia, and central facial weakness were more common among the nonamnestic MCI 
293 types than the amnestic types, while the frequency of the other Cs didn’t vary among the 4 MCI types. 
294 The  mean number of Cs was greater among the nonamnestic MCI types than the amnestic types.  Mild 
295 Parkinsonian Signs were found in 46,2% (n=578) of the sample. In all MCI types, bradykinesia was the 
296 most common MPS, followed by gait/balance/axial dysfunction, and tremor, while rigidity was the rarest. 
297 Individual MPS were more common among the MCI types multiple domain than the MCI  single domain. 
298 The mean number of MPS  was greater in the former than in the latter. Cerebellar-based signs  were the 
299 rarest ISNA encountered. Dysmetria was the most common CLs, and the atactic type gait was the rarest. 
300 The frequency of dysmetria didn’t vary among the 4 MCI types, while the atactic type gait was more 
301 common among the a-MCImd  than the other MCI types. The mean number of CLs didn’t vary among the 
302 MCI types.  
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303 ISNA increased with age reaching a peak in the old-oldest old individuals (Table 3). Among the 
304 adults, 210 subjects (65,8%) were ISNA+, and 109 subjects (34,2%) were ISNA-. PR were the most 
305 frequent ISNA followed by Cs, MPS, and CLs categories. PR. Cs, and MPS were  more common among 
306 the MCI types multiple domain than those single domain, while CLs didn’t vary in the 4 MCI types. The 
307 mean number of ISNA was greater in the former than in the latter. Within the elderly, 405 subjects 
308 (88,4%) were ISNA+, and 53 subjects (11,6%) were ISNA-. The frequency of subjects ISNA+ didn’t 
309 vary among the 4 MCI types. PR were the most frequent ISNA followed by Cs, MPS, and CLs categories. 
310 PR were almost equally distributed in the 4 MCI types, MPS and CLs were more common among the 
311 MCI types multiple domain, and Cs were more common among the nonamnestic MCI types. The mean 
312 number of ISNA was greater  in the nonamnestic MCI types, than in the amnestic  types.  Among the old-
313 oldest old subjects, 461 individuals (97,5%) presented at least one ISNA, and 12 individuals only (2,5%) 
314 were ISNA-. CLs and MPS didn’t vary among the 4 MCI types. Cs were significantly more common 
315 among the nonamnestic MCI types, while PR were significantly more common among the amnestic MCI 
316 type. The mean number of ISNA was significantly greater in the na-MCImd type than in the other MCI 
317 types. The co-occurrence of  multiple ISNA increased with age in all MCI types. 
318 Baseline characteristics of MCI types ISNA+ and  ISNA- are shown in Table 4. In all MCI types, no 
319 difference was found in the distribution of female and male among the two ISNA groups. In all MCI 
320 types, the  mean age of female  was greater in subjects ISNA+ than in subjects ISNA-, while the mean 
321 age of male was greater in subjects ISNA+ than in subjects ISNA- in the a-MCI only. Level of education 
322 didn’t vary  among the ISNA groups in MCI types single domain and in a-MCImd type, while in the na-
323 MCImd type subjects ISNA+ were less educated  than subjects ISNA-. The ADL scores were worse in 
324 the MCI types single domain ISNA+ only, and the IADL scores were worse in the MCI types single 
325 domain and a-MCImd ISNA+. In the na-MCImd type, ADL and IADL scores didn’t vary  among the two 
326 ISNA groups. Out of the VRF evaluated, arterial hypertension only was significantly more common 
327 among subjects ISNA+ than subjects ISNA- with the na-MCImd type, while no difference was found in 
328 the distribution of VRF among the two ISNA groups of the other MCI types. However, in a-MCI and na-
329 MCImd, the VRF summary score was greater in subjects ISNA+ than those ISNA-. No difference was 
330 found in the frequency of the VD evaluated among subjects ISNA+ and ISNA- of almost all MCI types, 
331 with the exception of history of TIA that was significantly more common among the subjects a-MCI 
332 ISNA+. The VD summary score  was greater in subjects ISNA+ than in those ISNA- in the  a-MCI only. 
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333 In the a-MCI type, APOE ε4 carriers were significantly more common in subjects ISNA+ than in subjects 
334 ISNA-, and APOE ε4 non carriers were significantly more common in subjects ISNA- than in subjects 
335 ISNA+. The distribution of APOE ε4 carriers and non carriers didn’t differ in the two ISNA groups of the 
336 other MCI types. 
337 Neuropsychological performances of MCI types ISNA+ and ISNA- are summarized in Table 5. The 
338 MMSE score was above the cut-off level in all MCI types, but subjects  a-MCI ISNA+ performed 
339 significantly less than subjects ISNA-. As expected, a worse performance on memory task was exhibited 
340 by the amnestic MCI types ISNA+ and ISNA-. In subjects with a-MCI, the nonmemory domains were not 
341 impaired, but subjects ISNA+ performed significantly less  than subjects ISNA- in attention, executive 
342 function, and language. In subjects a-MCImd ISNA+ and ISNA-, the nonmemory domains were 
343 impaired, and subjects ISNA+ performed significantly worse than subjects ISNA- in tests evaluating 
344 language. In the nonamnestic MCI types no significant difference was found in the performance of 
345 nonmemory domains among subjects ISNA+ and ISNA-, although a trend of worse performance of 
346 subjects ISNA+ in almost all cognitive domains  was evident.
347 Carotid ultrasonography and imaging findings in the MCI types ISNA+ and ISNA-  are reported in 
348 Table 6.  In all MCI types, the frequency of  IMT  was  significantly higher in subjects ISNA+ than 
349 subjects ISNA-, while the frequency of SICA didn’t differ between the two ISNA groups. In a-MCI, na-
350 MCI, and na-MCImd, WMH-SC, WMH-T, and WMH-PV were  significantly higher in subjects ISNA+ 
351 than subjects ISNA-, while in a-MCImd WMH-BG only were significantly higher in subjects ISNA+. 
352 Lacunes-BG and lacunes-T were significantly higher in MCI types single domain ISNA+,  and lacunes-T 
353 were significantly higher in na-MCImd ISNA+. In a-MCI, na-MCI, and na-MCImd, SVD+ was more 
354 common in subjects ISNA+ than ISNA-, while SVD- was more common among the subjects ISNA- than 
355 ISNA+. In a-MCImd,  the distribution of subjects SVD+ and SVD- didn’t differ among the two ISNA 
356 groups. BCr was significantly higher in all MCI types ISNA+ with the exception of a-MCImd type. LVBr 
357 was significantly higher in the MCI types single domain ISNA+, while no difference among the ISNA 
358 groups was found  in the MCI types multiple domains. 
359  To assess the effects of  the variables evaluated on the estimated probability of having at least one 
360 ISNA, logistic ridge regression analysis was carried out in each MCI type (Table 7). Age resulted 
361 associated with a-MCI type only. For each year of age increase, the odds of  having at least one ISNA 
362 went up about 3%. Being female increased by 7,7% the probability of having at least one ISNA in the a-
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363 MCI type only. Education, and VRF summary score didn’t influence the probability of having at least one 
364 ISNA in any of the MCI types. VD summary score increased the probability of having at least one ISNA 
365 in a-MCI (18,1%), na-MCI (11,1%), and na-MCImd (4,5%). Being carrier of the APOE ε4 allele 
366 increased by 52,7%,  16,5%, and 5,1%  the probability of having at least one ISNA in  a-MCI, a-MCImd, 
367 and na-MCImd, respectively. At the increase of a single percentage point of the IMT the probability of 
368 having at least one ISNA  in a-MCI, a-MCImd, na-MCI, and na-MCImd went up  by  52,7%, 36,9%, 
369 14,8%, and 16,3%, respectively.  The presence of WMH-PV increased by 36,7%, 58,4%, and 14,3% the 
370 probability of having at least one ISNA  in  a-MCI, na-MCI, and  na-MCImd, respectively. The presence 
371 of SVD in the frontal region increased the risk of having at least one ISNA  in a-MCI (16,4%), na-MCI 
372 (54,5%), and na-MCImd (16%) types. The presence of SVD in the parieto-occipital region  increased the 
373 risk of having at least one ISNA   in a-MCI, na-MCI, and na-MCImd by 22,3%, 30,3%, and 10,5%, 
374 respectively.  The presence of SVD in the lateral temporal region increased the risk of having at least one 
375 ISNA in a-MCI, a-MCImd, na-MCI, and na-MCImd MCI  by 14,0%, 15,9%, 19,8%, and 8,4%, 
376 respectively. The presence of SVD in the basal ganglia increased the risk of having at least one ISNA in 
377 a-MCI, a-MCImd, na-MCI, and na-MCImd by 29,9%, 31,1%, 51,8%, and 9,7%, respectively. BCr, and 
378 LVBr resulted associated with all the MCI types.  At the increment of a single percentage point of  BCr, 
379 the probability of having at least one ISNA  increased by 15,6% in a-MCI, 31,9% in a-MCImd, 65,8% in 
380 na-MCI, and 32,4% in na-MCImd.  At the increment of a single percentage point of LVBr, the odds of 
381 having at least one ISNA  increased by 13,1% in a-MCI, 6,2% in a-MCImd, 9,6% in na-MCI, and 5,2% in 
382 na-MCImd. 
383
384
385 DISCUSSION
386           The frequency of ISNA detected in subjects with MCI was greater (86%) than that found in NCH 
387 aging individuals (57,2%).20 In all MCI types, and in all age classes, PR were the ISNA most frequently 
388 encountered, followed by Cs, MPS, and CLs. All ISNA categories increased with age, and were presented 
389 by both the amnestic and nonamnestic MCI types, particularly by those  multiple domain, with the 
390 exception of Cs and PR that in the old-oldest old subjects were more common among the MCI types 
391 single domain. 
392           Copious data of the literature underline  the importance of midlife vascular risks and Aβ burden to 
393 neurodegenerative processes, and to the development of cognitive decline in older adults. In CN 
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394 individuals,  midlife VRF accelerate structural brain aging,42 are associated with greater  prospective 
395 cognitive decline,43 current and later-life smaller brain volumes,44 and risk of dementia.45 Further, midlife 
396 but not later-life exposure to VRF is important also for Aβ deposition, as shown by the fact that having 2 
397 or more midlife VRF compared with none is significantly associated with elevated Aβ deposition (61.2% 
398 vs 30.8%).46 In addition, in CN and  MCI  individuals, VRF  interact with Aβ to reduce cortical thickness 
399 in frontotemporal and parietal regions vulnerable to AD,47 and are associated with prospective cognitive 
400 decline, both alone and synergistically with Aβ burden.48 However, VRF summary score was not 
401 associated with ISNA in any of the 4 MCI types, and VD summary score increased the probability of 
402 having at least one ISNA in the MCI types single domain, and poorly in the na-MCImd. These data need 
403 attention. A high vascular risk burden at younger ages is indeed indicative of early vascular aging,49 but in 
404 the later years of life it is less relevant regarding the MCI typology since vascular and neurodegenerative 
405 processes have already occurred at younger ages when the MCI typology is likely to be of single domain 
406 type. The fact that subjects with MCI types multiple domain were older than subjects with MCI types 
407 single domain supports this hypothesis.  IMT increased the probability of  having at least one  ISNA in all 
408 MCI types, and the risk was greater for the amnestic MCI types than for the nonamnestic types.  These 
409 results are in agreement with a previous study showing that IMT is associated with WMH, infarcts, brain 
410 atrophy, and with poor cognitive performance particularly in the executive function.50 Further, IMT 
411 significantly increases the risk of conversion of a-MCI to dementia.51 WMH-PV increased greatly the 
412 probability of having at least one ISNA in MCI types single domain, and in the na-MCImd.  It has been 
413 shown that WMH-PV are associated with elevated Aβ deposition independently from age and presence of 
414 APOE ε4 allele,52 and  induce thinning of prefrontal, parietal, temporal cortices, anterior insula, and 
415 atrophy of the caudate nuclei,14 and cognitive decline through the cortical atrophy of the above 
416 disconnected regions.19 Therefore, it is reasonable  to suspect that  even in our MCI types WMH-PV may 
417 also have induced atrophy of the caudate nuclei, and thinning of  the frontal, parietal, and temporal 
418 cortices through likely disruption of periventricular long associating tracts.  
419           Overall, SVD at different topographical locations, and BCr greatly increases the risk of having  
420 ISNA in all the MCI types. Given that cortex, cerebellum, and BG are strictly interconnected,53  it is 
421 likely that ISNA are the by-product of the disconnection of the cortical-cerebellar-basal ganglia-thalamo-
422 cortical circuits induced by vascular and degenerative processes. It is also likely that the caudate atrophy 
423 and  the disruption of the internal circuits of  BG may have induced  an excessive inhibition to its output 
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424 nuclei. As a consequence, the inhibitory drive to thalamus  may have led to bradykinesia, and that to 
425 brainstem structures controlling postural muscle tone and locomotion may have led to rigidity and 
426 gait/balance/axial dysfunction respectively,54 while the inhibition of the physiological inhibitor control of 
427 lower brainstem centres on stereotyped motor responses55 may have led to the reappearance of  PR.    
428           Nevertheless, the above hypotheses underpinning the vascular contribution to ISNA do not fully 
429 explain their presentation in the various MCI types.  Among the amnestic MCI types,  39% (n=342) of 
430 subjects ISNA+ were SVD-, and 5% (n=45) of  subjects ISNA- were SVD+. Similarly, among the 
431 nonamnestic MCI types 51% (n=190) of subjects ISNA+ were SVD-, and 35% (n=130) of  subjects 
432 ISNA- were SVD+. These conflicting data suggest that co-occurring factors others than vascular 
433 contribute to the presentation of  ISNA. The APOE ε4 allele can be one of these factors.  In the present 
434 study, the APOE ε4 carriers were indeed over-represented relative to other studies, probably because the 
435 CogItA study  assessed essentially subjects referred to the memory clinic, making the sample vulnerable 
436 to selection. Overall, APOE ε4 carriers were more common among subjects ISNA+ than subjects ISNA- 
437 in all MCI types, and  being ε4 carrier increased the probability of having at least one ISNA greatly in the 
438 amnestic MCI types and scarcely in the nonamnestic MCI types, a finding in agreement with the notion 
439 that compared to non ε4 carriers, MCI ε4 carriers have frequently the amnestic phenotype.56 The presence 
440 of APOE ε4 allele in nonamnestic MCI types is not surprising. Along with age, APOE ε4 allele is a 
441 significant predictor of  amyloidosis. More than half of all MCI types is Aβ positive,57 and  APOE ε4 
442 carriers are 2-3 times more likely to be amyloid positive than APOE ε4 non carriers.6 Subjects with MCI 
443 have elevated Aβ deposition  in frontal, parietal, temporal, and posterior cingulate cortices suggestive of 
444 early AD process,58 and those converting to AD  have a greater Aβ deposition in these regions, as well as 
445 in the putamen and in the caudate nuclei  as compared to nonconverters.59   Furthermore, in subjects with 
446 MCI the presence of the APOE ε4 allele is more frequent in the converters than in the nonconverters.60 
447 Therefore, it is reasonable to suspect that subjects of all 4 MCI types carrying the APOE ε4 allele were 
448 also Aβ positive, and that subjects ISNA+ being more APOE ε4 carriers than subjects ISNA- were 
449 candidates to convert  to dementia faster than subjects ISNA-.
450
451 Limitations of the study
452           Some limitations of  our study are worth noting. First, CSF biomarkers of Aβ and tau, and 
453 advanced imaging techniques up to now are not fully available in our country, particularly  in a clinical 
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454 setting. So, we do not know the distribution of Aβ and tau  in subjects ISNA+ and ISNA- of the various 
455 MCI types. Second, we assessed cortical and subcortical atrophy using linear measurements well aware 
456 that  they are rather crude estimates of brain atrophy. However, it has been shown that the bicaudate ratio 
457 is a reliable marker of caudate atrophy,61 and that ventricular enlargement is a feasible, even if 
458 nonspecific, surrogate marker of neurodegeneration in MCI and AD.16 Third, we didn’t estimate WMH 
459 volumetrically, but visually. However, it has been shown that WMH evaluated with visual scales correlate 
460 well with WMH volumetry.62  Fourth, perhaps we underestimated the magnitude of cerebral SVD in our 
461 cohort, because we evaluated WMH and lacunes only.  Fifth, the generalizability of our results is limited 
462 because the patients have been selected in a hospital setting. Sixth, in the present paper there is not 
463 mention of  the ISNA in neurologically and cognitively normal subjects because data on this topic has 
464 been already published.20 Lastly, the cross-sectional design of our study doesn’t allow causal inferences. 
465
466 CONCLUSION 
467           ISNA are likely to have a multifactorial origin, increase with age, and are presented by both the 
468 amnestic and nonamnestic MCI types, particularly by those multiple domain, and carrying the APOE ε4 
469 allele. Further, subjects ISNA+ perform less than subjects ISNA- in almost all nonmemory domains. 
470 Given that cortical and subcortical vascular and  atrophic processes contribute to ISNA, their presence in 
471 individuals with MCI must alert the practitioners to target timely interventions to slowing cognitive 
472 decline and delay progression of MCI to dementia. Longer prospective population-based studies are 
473 needed to clarify to what extent the presentation of ISNA  in middle-aged and older MCI individuals 
474 represents  an additive risk  for  the conversion to dementia.
475
476
477
478
479
480
481
482
483
Page 16 of 46
17
484 ACKNOWLEDGEMENTS
485 We gratefully thank all participants, as well as the neurologists and the neuropsychologists who over time 
486 collected  patients data.
487
488 STATEMENT OF AUTHORSHIP
489 CC and RC were responsible for the study’s concept and design, data managements, and record linkage. 
490 GS and GC did the statistical analysis. CC, PT, CP, DA, and RC contributed to the analysis and 
491 interpretation of the data.
492 CC wrote the paper. All co-authors edited the paper, and approved its final version.
493
494
495 DISCLOSURES
496 All the authors hereby declare that they have nothing to disclose.   
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
Page 17 of 46
18
531 REFERENCES
532
1. Petersen RC, Smith GE,  Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: 
clinical characterization and outcome. Arch Neurol. 1999; 56:303-308.
2. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004; 256:183-194.   
3. Jack RC Jr. Brain Atrophy on Magnetic Resonance Imaging as a Biomarker of Neurodegeneration. 
JAMA Neurol. 2006; 73:1179-1182.
4. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of 
dementia due to Alzheimer’s disease:recommendations from the National Institute on Aging-
Alzheimer’s Association workgroups on diagnostic guide-lines for Alzheimer’s disease. Alzheimers 
Dement. 2001; 7: 263-269.
5. Albert MS, Dekosky ST, Dickson D,  Dubois B, Feldman HH, Fox NC, et al. The diagnosis of  mild 
      cognitive impairment due to Alzheimer’s disease: recommendations from the National  Institute on 
Aging and Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. 
Alzheimers Dement. 2011; 7:270-279.
6. Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, et al. Prevalence of cerebral 
amyloid pathology in persons without dementia: a meta-analysis. JAMA 2015; 313:1924-1938.
7. Jack CR Jr,  Wiste HJ,  Schwarz CG,  Lowe VJ, Senjem ML, Vemuri  P, et al. Longitudinal tau PET in 
ageing and Alzheimer’s disease. Brain. 2018; 141: 1517-1528.
8. Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, et al. Criteria for mild cognitive 
impairment due to Alzheimer disease in the community. Ann Neurol. 2013; 74:199-208.
9. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic 
challenges. Lancet Neurol. 2010; 9: 689-701.  
10. Luchsinger JA, Brickman AM, Reitz C, Cho SJ, Schupf N, Manly JJ, et al. Subclinical cerebrovascular 
     disease in mild cognitive impairment. Neurology. 2009; 73:450-456.
11. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions  to 
cognitive impairment and dementia: a statement for healthcare professionals from the American  
      Heart Association/American Stroke Association. Stroke. 2011; 42:2672-2713.
12. Wardlaw JM, Smith C, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards  
Page 18 of 46
19
     for  research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet  
Neurol. 2013; 12: 822-838.
13. Reijner YD, Freeze WM, Leemans A, Biessels GJ. The effect of lacunar infarcts on white matter tract integrity. 
Stroke. 2013; 44:2019-2021.
14. Lambert C, Narean JS, Benjamin P, Zeestraten E, Barrick TR, Markus HS.  Characterising the grey  
matter correlates of leukoaraiosis in cerebral small vessel disease. Neuroimage Clin. 2015; 9:194-205.
15. Thong JY, Hilal S, Wang Y, Soon HW, Dong Y, Collinson SL, et al. Association of silent lacunar  infarct with 
brain atrophy and cognitive impairment. J Neurol Neurosur Ps. 2013; 84:1219-1225.    
16. Madsen SK, Gutman BA, Joshi SH, Toga AW, Jack CR Jr, Weiner MW, et al. Mapping ventricular expansion 
onto cortical gray matter in older adults. Neurobiol Aging. 2014; 36 (Suppl 1): S32-S41.
17. Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, et al. Regional brain  
changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex. 
2005; 15: 1676-1689.
18. Habes M, Erus G, Toledo JB, Zhang T, Bryan N, Launer LJ, et al. White matter hyperintensities and  
      imaging  patterns of brain ageing in the general population. Brain. 2016; 139: 1164-1179.
19. Rizvi B, Narkhede A, Last BS, Budge M, Tosto G, Manly JJ, et al. The effect of white matter  
      hyperintensities on cognition is mediated by cortical atrophy. Neurobiol Aging. 2018; 64: 25-32.
20. Camarda C, Torelli P, Camarda R, Battaglini J, Gagliardo C, Monastero R. Isolated, Subtle,  
     Neurological  Abnormalities in Neurologically and Cognitively Healthy Aging Subjects.  J Neurol. 
     2015;  262:1328-1339.
21. Louis ED, Schupf N, Manly J, Marder K,Tang MX, Mayeux R. Association between mild parkinsonian 
     signs   and mild cognitive impairment in a community. Neurology. 2005; 64:1157-1161. 
22. Boyle PA, Wilson RS, Aggarwal NT, Arvanitakis Z, Kelly J, Bienias JL, et al. Parkinsonian signs in  
     subjects with mild cognitive impairment. Neurology. 2005; 65:1901-1906.
23. Folstein MF, Folstein SE,  McHugh PR. Mini-mental State: a practical method  for grading the cognitive 
      state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198 .
24. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia  of 
the Alzheimer type. Int  Psychogeriatr. 1997; 9:173-176.  
25. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of
Page 19 of 46
20
ADL: a standardized measure of biological and psychosocial function. JAMA. 1963; 185: 914-919.                        
26. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of  
daily living. Gerontologist. 1969; 9:179-186.                                                                      
27. McKeith IG,  Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines  for the 
clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on 
DLB International Workshop. J Alzheimers Dis. 2006; 9: 417-423.
28. Brun A,Englund B,Gustafson L,Passant U,Mann DMA,Neary D, et al.Clinical and  neuropathological 
criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosur 
Psychiatry.1994; 57: 416-418.
29. Camarda C, Torelli P, Pipia C, Azzarello D, Battaglini I, Sottile G, Cilluffo G, Camarda R. Nociceptive 
primitive reflexes in neurologically and cognitively healthy aging subjects. Canad J Neurol Sci. 2019; 
46:199-208.
30. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and  cleavage 
with Hhal. J Lipid Res. 1982; 31: 545-548.
31. Rossor MN. Snouting, poting and rooting. Pract Neurol. 2001; 1:119-121.
32. Schott JM, Rossor MN. The grasp and other primitive reflexes. J Neurol Neurosur Psychiatry. 2003;
      74:558-560.
33. Louis ED, Bennett DA. Mild Parkinsonian Signs: an overview of an emerging concept. Mov Disord. 
     2007; 22:1681-1688.
34. Fahn S, Elton RL and the members of the UPDRS development committee. Unified Parkinson’s  
      Disease Rating Scale. In Fahn S, Marsden CD, Goldstein M, Calne DB (Eds). Recent Developments 
      in Parkinson’s Disease. London, MacMillan Healthcare Information pp. 153-163 (1987).
35. Camarda C, Pipia C, Azzarello D, Battaglini I, Romeo G, Chiodi M, et al. Vascular Risk Factors,  
Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment  
Types. Current Alzheimer Dis .2018; 15: 679-690.
36. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic 
reliability and qualitative analyses of cognitive impairment: the Group for the Standardization of the  
Mental Deterioration  Battery. Eur Neurol. 1996; 36: 378-384.
37. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A new rating scale for  
Page 20 of 46
21
     age-related  white matter changes applicable to MRI and CT. Stroke. 2001; 32: 1318-1322.
38. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in 
      Alzheimer’s  dementia and normal aging. AJR Am J Neuroradiol. 1987; 8:421-426.     
39. Hoerl AE, Kennard RW. Ridge regression: Biased estimation for nonorthogonal problems.
     Technometrics. 1970; 12: 55-67.
40. El-Dereny M, Rashwan NI.  Solving multicollinearity problem using ridge regression models.  Int J  
     Contemp Math Sciences. 2011;  6: 585-600.
41. Goeman JJ. L1 penalized estimation in the Cox proportional hazards model. Biom J. 2010; 52:70-84.  
42. Debette S, Seshadri S, Beiser A,  Au R, Himalim JJ, Palumbo C,  et al. Midlife  vascular  risk factor  
      exposure accelerates structural brain aging and cognitive decline. Neurology. 2011; 77:461-468.
43. Gottesman RF, Schneider AL, Albert M,  Alonso A, Bandeen-Roche K, Coker L, et al. Midlife  
      hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive  
      study. JAMA Neurol. 2014; 71:1218-1227.
44. Pase MP, Davis-Plourde K, Himali JJ, Satizabal CL, Aparicio H, Seshadri S, et al. Vascular risk at  
      younger ages most strongly associates with current and future brain volume. Neurology. 2018;  91:
      1479-1486.
45. Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K. Bodymass index in midlife and risk
      of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 2007;  4:103-109.
46. Gottesman RF, Schneider AL, Zhou Y, Coresh J, Green E, Gupta N, et al. Association between midlife 
vascular risk factors and estimated brain amyloid deposition. JAMA. 2017; 317:1443-1450. 
47. Villeneuve S., Reed  BR, Madison CM, Wirth M, Marchant NL, Kriger S, et al. Vascular risk and Aβ  
      interact to reduce cortical thickness in AD vulnerable brain regions. Neurology. 2014; 83: 40-47.   
48. Rabin JS, Schultz AP, Hedden T, Viswanathan A, Marshall GA, Kilpatrick E, et al. Interactive  
Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal  
Elderly Individuals. Findings From the Harvard Aging Brain Study. JAMA Neurol. 2018; 75: 1124-
1131. 
49. Nilsson PM. Early vascular aging (EVA): consequences and prevention. Vasc Health Risk Manag. 2008;
      4:547-552.
50. Romero JR, Beiser A, Seshadri S, Benjamin EJ, Polak JF, Vasan RS, et al. Carotid artery  
Page 21 of 46
22
atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham 
study. Stroke. 2009;  40:1590-1596.
51. Viticchi G, Falsetti L,Vernieri F, Altamura C, Bartolini M, Luzzi S, et al.Vascular predictors of  
cognitive decline in patients with mild cognitive impairment. Neurobiol Aging. 2012;  33: 
1127. e1-9.
52. Marnane M, Al-Jawadi OO, Mortazavi S, Pogorzelec KJ, Wang BW, Feldman HH, et al. 
Periventricular hyperintensities are associated with elevated cerebral amyloid. Neurology.2016; 
86:1-9.
53. Caligiore D, Strick PL, Jörntell H, Popa T, Herreros I, Pezzulo G, et al. Consensus Paper: Towards a 
      Systems-LevelView of Cerebellar Function: the Interplay Between Cerebellum, Basal Ganglia, and  
Cortex. Cerebellum. 2017; 16:203-229.
54. Takakusaki K. Neurophysiology of gait: from the spinal cord to the frontal lobe. Mov Disord. 2013; 
     28:1483-1491.
55. Delwaide PJ, Dijeux L. Réflexes néonateaux et dyskinésies bucco-linguo-faciales dans la démence sénile. 
     Neonatal reflexes and bucco-linguo-facial dyskinesias in senile dementia.L’Actualité en Gérontologie. 
1980; 6:126-33.
56. Snowden JS, Stopford CL,Julien CL,Thompson JC,Davidson Y, Gibbons L, et al. Cognitive phenotypes 
      in Alzheimer’s disease and genetic risk. Cortex. 2007;43:835-845.
57. Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, et al.Amyloid imaging in mild  cognitive 
impairment subtypes. Ann Neurol. 2009;  65:557-568.
58. Kemppainen NM, Aalto S, Wilson IA,  Någren K, Helin S, Brück A, et al. PET amyloid ligand [C-11]  
      PIB uptake is increased in mild cognitive impairment. Neurology. 2007;  68:1603-1606.
59. Koivunen J, Scheinin N., Virta JR, Aalto S, Vahlberg T, Någren K, et al. Amyloid PET imaging in   
     patients with mild cognitive impairment. A 2-year follow-up study. Neurology. 2011; 76:1085-1090.
60. Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Någren K, et al. Conversion of amyloid 
     positive and negative MCI to AD over 3 years: an11C-PIB PET study. Neurology. 2009; 73:754-760.  
61. Doraiswamy PM, Patterson L, Na C, Husain MM, Boyko O,  McDonald WM, et al.  Bicaudate index on 
magnetic resonance imaging: effects of normal aging. J Geriatr Psych Neurol. 1994; 7: 13-17.
62. Gao F, Swartz RH, Scheltens P, Leibovitch FS, Kiss A, Honjo K, et al. Complexity of MRI White matter 
Page 22 of 46
23
hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook 
Dementia Study. J Alzheimers Dis. 2011; 26: 379-388.
533
Page 23 of 46
11 Isolated, Subtle, Neurological Abnormalities in Mild Cognitive Impairment Types 
2
3
4
5
6  
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
Page 24 of 46
234 Isolated, Subtle, Neurological Abnormalities in Mild Cognitive Impairment Types 
35
36
37
38 Cecilia Camarda1, Rosolino  Camarda2, Carmela Pipia3, Delia Azzarello2, Emanuele Grassedonio1, 
39 Gianluca Sottile4, Giovanna Cilluffo5,  Paola Torelli6.    
40
41
42
43
44
45 1 Department of Biomedicine, Neurosciences, and advanced Diagnostics, University of Palermo, Palermo, 
46 Italy;2Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo, 
47 Palermo, Italy; 3Fondazione “Salvatore Maugeri”, Sciacca, Italy; 4Department of Economics, Business, 
48 and Statistics Sciences, University of Palermo, Palermo, Italy; 5Institute of Biomedicine and Molecular 
49 Immunology, National Research Council, Palermo, Italy; 6Department of  Clinical and Experimental 
50 Medicine, University of Parma, Parma, Italy.
51
52
53
54
55
56
57
58 Correspondence to: 
59 Cecilia Camarda, Department of Biomedicine, Neurosciences, and advanced Diagnostics, University of 
60 Palermo, via G. La Loggia,1-90139 Palermo, Italy. Email: cecilia.camarda@unipa.it
61 Gianluca Sottile, Department of Economics, Business, and Statistics Sciences, University of Palermo, 
62 viale delle Scienze, bldg. 13,  90128 Palermo, Italy. Email: gianluca.sottile@unipa.it
63
Page 25 of 46
364 Abstract
65
66 Background: Isolated, subtle neurological abnormalities (ISNA) are commonly seen in aging, and 
67 have been related to cerebral Small Vessel Disease (SVD) and subcortical atrophy in neurologically 
68 and cognitively healthy aging subjects.
69
70 Objective: To investigate the frequency of ISNA in different MCI types, and to evaluate for each 
71 MCI type  the cross-sectional relation between ISNA and white matter hyperintensities (WMH), 
72 lacunes, caudate atrophy, and ventricular enlargement.
73
74 Methods: 1,250 subjects with different MCI types were included in the analysis, and  underwent 
75 brain MRI. WMH were assessed through two visual rating scales. Lacunes were also rated. Atrophy 
76 of the caudate nuclei and ventricular enlargement were assessed through the bicaudate ratio (BCr) 
77 and the lateral ventricles to brain ratio (LVBr), respectively. Apolipoprotein E (APOE) genotypes 
78 were also assessed. The routine neurological examination was used to evaluate ISNA that were 
79 clustered  as central-based signs, cerebellar-based signs, and primitive reflexes. The items of Part-III 
80 of the Unified Parkinson’s Disease Rating Scale were used to evaluate ISNA that were clustered as 
81 mild parkinsonian signs.  Associations of  ISNA with imaging findings was determined through 
82 logistic regression analysis. 
83
84 Results: The ISNA increase with the age, are present in all MCI types, particularly in those  
85 multiple domains, and carrying the APOE ε4 allele, and are associated with WMH, lacunes, BCr, 
86 and LVBr.
87
88 Conclusion: This study demonstrates that cortical and subcortical vascular and atrophic processes 
89 contribute to ISNA. Long prospective population-based studies are needed to disentangle the role of 
90 ISNA in the conversion from MCI  to dementia.
91
92
93
94
95
96
Page 26 of 46
497 Keywords: Isolated, subtle, neurological abnormalities, Mild cognitive impairment types, White matter 
98 hyperintensities, Lacunes, Caudate atrophy, Global cerebral atrophy
99
100
101
102
103
104 Running title: ISNA in MCI types.
105
106
107
108
109
110
111 Words count of the title: 9
112 Words count of the title page: 132
113 Words count of the abstract: 247
114 Words count of the keywords: 18
115 Words count of the Introduction: 651
116 Words count of the Methods:1178 
117 Words count of the Results: 1747 
118 Words count of the Discussion:1189
119 Words count of the Conclusion:114
120 Words count of the body of  the manuscript:  4879
121
122 Total words of the manuscript: 5,277
Page 27 of 46
5123 INTRODUCTION
124
125
126           Mild cognitive impairment (MCI) is a term that refers to a condition in which an essentially spared 
127 global cognition, and normal or slightly impaired activities of daily living coexist with a mild decline of 
128 cognitive functions greater than that expected for age and education.1,2  Four MCI phenotypes have been 
129 recognized2 as follows: amnestic MCI single domain (a-MCI), amnestic MCI multiple domain (a-
130 MCImd), nonamnestic MCI single domain (na-MCI), and nonamnestic MCI multiple domain (na-
131 MCImd). Extracellular deposition of β-amyloid (Aβ) peptide, intracellular deposition of hyper-
132 phosphorilated tau protein, and atrophy of frontal, parietal, and medial temporal cortices, i.e. 
133 neurodegeneration of  AD signature cortical regions,3 are the  key elements of  the pathophysiology of 
134 Alzheimer disease (AD),4 and MCI due to AD.5 The prevalence of Aβ positivity among subjects with 
135 MCI  increases from age 50 to 90 years from 27%  to 71%; nonamnestic MCI types have lower 
136 prevalence estimates of Aβ positivity than amnestic MCI types, but higher than subjects cognitively 
137 normal (CN), and both amnestic and nonamnestic MCI are at increased  risk for AD.6  Concerning tau, 
138 MCI and AD individuals have tau accumulation in the basal and mild-temporal, retrosplenial, posterior 
139 cingulate, and enthorinal regions greater than CN individuals Aβ positive.7 
140           The observation that  21,5% and 35% of individuals with amnestic and nonamnestic MCI types, 
141 respectively, are Aβ negative,8 has  suggested  that these individuals are not on the AD pathway, and that 
142 vascular pathology may be one of the possible  non-AD causes  of MCI. Among vascular pathology, 
143 cerebral small vessel disease (SVD) plays a pivotal role.  SVD  affects the smallest cerebral small vessels, 
144 increases throughout the lifespan,9 and contributes to the risk of MCI,10 and dementia.11 White matter 
145 hyperintensities (WMH), lacunes,  small subcortical infarcts, microbleeds, enlarged perivascular spaces, 
146 and central atrophy are the imaging markers of SVD.12 Lacunes13 and WMH14 disrupting  locally  the  
147 structural integrity of white matter induce thinning of the connected cortical regions through Wallerian 
148 degeneration. Lacunes are associated with widespread cortical thinning, atrophy in multiple subcortical 
149 structures, and ventricular enlargement.15 In subjects with MCI, expansion of the lateral ventricles is 
150 associated with atrophy of frontal, parietal, and  temporal regions affected by AD.16 Furthermore, age per 
151 se is associated with atrophy of the cerebellum, striatum, and prefrontal, parietal, and temporal 
152 association cortices.17 The pattern of  cortical atrophy induced by severe WMH overlaps substantially 
153 with the patterns of age-related cortical atrophy and of AD-related cortical atrophy.18 Since cortical 
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6154 atrophy induced by WMH drives cognitive decline,19 age and SVD may contribute to the onset of 
155 cognitive decline through the overlapping atrophy of cortical regions vulnerable to AD pathology. 
156 Cerebral SVD, Aβ, tau, and atrophic changes fragmenting over time brain networks into 
157 disconnected parts not only contribute to cognitive decline, but also contribute to the presentation of a 
158 wide range of neurological signs. We have shown that neurologically and cognitively  healthy (NCH) 
159 aging subjects frequently present at the routine neurological examination isolated, subtle, neurological 
160 abnormalities (ISNA) which do not have any immediate diagnostic relevance, cannot be attributed to any 
161 definite, overt neurological disease, are associated with atrophy of the caudate nuclei, and with parietal 
162 WMH and lacunes, and probably constitute a red flag for future cognitive decline given that they show 
163 poor performance in test evaluating  global cognition, executive function, and language.20 Past reports on 
164 neurological signs in MCI have primarily focused on extrapyramidal features,21,22 while reports on signs 
165 others than extrapyramidal are sparse. Therefore, the aims of our study are: 1) to investigate  the 
166 prevalence of  ISNA  in  the 4 MCI types; 2) to verify whether in the individual MCI types  the 
167 probability of having  ISNA is differently associated with the topographical location of WMH and  
168 lacunes, periventricular WMH (WMH-PV), APOE ε4 allele, and  with two linear measures of  central 
169 atrophy,12  i.e. the bicaudate ratio (BCr) as proxy of subcortical atrophy, and the lateral ventricles to brain  
170 ratio (LVBr) as proxy of  global brain atrophy.  In the present paper, the terms  “adult”, “elderly”, “old”, 
171 and “oldest-old” will be used  to indicate  people aged 45-64, 65-74, 75-84, and >85 years respectively.
172
173
174 METHODS
175 Participants
176         Data were used from the Cognitive Impairment through Aging (CogItA) study, a hospital-based 
177 prospective study focused on normal and pathological aging in middle-aged and older individuals 
178 launched in January, 2000. CogItA’s participants were outpatients self-referred or referred by general 
179 practitioners for neurological and/or cognitive screenings to the clinics of the Department of Neurology 
180 and Cognitive Disorders of the teaching Hospital (AOUP “P.Giaccone”) of the School of Medicine of the 
181 University of Palermo, Italy. Details of the inclusion and exclusion criteria of the CogItA study have been 
182 reported elsewhere.20 Informed consent was obtained from all participants and relatives. The study was 
183 approved by the University Hospital ethics committee, and complies with  the declaration of Helsinki.
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7184          According to the published criteria,1,2 CogItA participants with preserved global cognition at the 
185 Mini-Mental State examination (MMSE score ≥ 23,74),23 subjective cognitive concerns, objective 
186 impairment in one or more cognitive domains, Clinical Dementia Rating (CDR) = 0.5),24 no impaired or 
187 minimally impaired functional status on the activities of daily living (ADL)25 and the instrumental 
188 activities of daily living (IADL) 26 scales, and no dementia were classified as MCI and categorized as a-
189 MCI, a-MCImd, na-MCI, and  na-MCImd. MCI subjects included in the present paper were stroke-free 
190 first ever diagnosed cases (n=1,250) aged 45-95 years (mean age = 70,52 ± 9,41 years), who remained in 
191 the MCI status for at least 3 years (mean follow-up = 64,98 ± 28,94 months). During this period, some of 
192 these subjects changed their MCI typology, but in the present paper first-ever MCI diagnoses were 
193 considered. Subjects who during the follow-up  reverted to normal cognition, or converted to dementias 
194 different from AD and Vascular Dementia (VaD) were not considered.   
195
196 Baseline Clinical Assessment
197           Participants to the present study underwent an extensive assessment of variables such as 
198 demographics, medical history, laboratory tests, neurological, and functional examinations, cognitive 
199 testing, carotid ultrasonography, and brain magnetic resonance imaging (MRI). Many vascular risk 
200 factors (VRF) and  vascular diseases (VD) were considered and assessed as reported elsewhere.20,29 Since 
201 multiple VRF and VD often coexist, we created the VRF and VD summary scores indicating for each 
202 participant the sum of the individual VRF and VD that were concurrently present. APOE genotypes were 
203 determined by using standard methods.30 Participants with at  least 1 APOE ε4 allele were classified as 
204 APOE ε4 carriers.
205
206 Assessment of  ISNA 
207         All participants underwent a standardised neurological examination reflecting that routinely 
208 performed in the clinical practice. Subjects presenting at baseline or during follow-up meaningful 
209 neurological signs such as visual field defects, language deficits, cranial nerves deficits, hemimotor and 
210 hemisensory dysfunction, brachial or crural weakness, brachial or crural sensory dysfunction, Babinski 
211 sign, spastic rigidity, and hemiplegic gait were excluded. The ISNA evaluated were: 1) mild dysphagia, 2)  
212 slurred speech,  3) central facial weakness, 4) mixed rigidity, i.e. a condition in which spastic and plastic 
213 rigidity coexist; 5) hyperreflexia (bilateral increased deep tendon reflexes), 6) reflex asymmetry, 7) 
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8214 tremor (resting tremor, and postural/kinetic tremor), 8) plastic rigidity,  9) bradykinesia,  10) 
215 gait/balance/axial dysfunction, 11) dysmetria, 12)  atactic type gait  defined as a gait pattern broadly 
216 indicative of cerebellar involvement, and 13) primitive reflexes (PR) i.e. glabellar tap, snout, 
217 palmomental, grasping, and sucking reflexes.31,32 To evaluate tremor, rigidity, bradykinesia, and 
218 gait/balance/axial dysfunction, collectively called  Mild Parkinsonian Signs (MPS),33 the items of motor 
219 section of the Unified Parkinson’s Disease Rating Scale (UPDRS)34 were used, and were considered 
220 present when any one of the following condition was met:  (1) two or more  items with a score of 1; or (2) 
221 one item with a score ≥ 2.21 The ISNA were dichotomised as absent (score = 0) or present (score = 1), and 
222 were clustered  into four categories as following: central-based signs (Cs) (signs 1-6), Mild Parkinsonian 
223 Signs (MPS) (signs 7-10), cerebellar-based signs (CLs) (signs 11-12), and PR (signs 13). We defined the 
224 presence of  Cs, MPS, CLs, and PR as the presence of  at least  one sign within  those included  in each of 
225 these clusters. Accordingly, subjects were divided into subjects without ISNA (ISNA-), and with ISNA 
226 (ISNA+) if at least one sign within the above clusters was present. The neurological examination of each 
227 participant was always performed by two neurologists blinded to the patients  history and neuroimaging. 
228 The interrater reliability assessed over time  in  random samples showed always excellent agreement with 
229 weighted Cohen’s kappa ranging between 0.88 and 0.91 (p< 0.001).   
230  
231 Functional and Neuropsychological Assessments 
232 The functional status of participants was assessed through the ADL and the IADL scales. Cognitive 
233 functions were assessed using an extensive neuropsychological battery as reported elsewhere,20,35 
234 including the MMSE as test of global cognition, and  12   tests  to evaluate  memory, attention, executive 
235 function, language, constructional ability, and  visuospatial skill. Impaired cognitive domains were 
236 identified using a cut-off of 1,5 standard deviation (SD)2 below the Italian normative data adjusted for 
237 age-, sex-, and education.36
238
239 Carotid Ultrasonography and Imaging Assessments
240 Intimal-medial thickness (IMT), and stenosis of internal carotid arteries (SICA) were assessed as 
241 reported elsewhere.20 Participants had brain MRI  on a 1,5T scanner (GE Signa HDxt, Milwaukee, WI, 
242 USA).  Details of the image acquisition protocol have been  published previously.20  The BCr and the 
243 LVBr were calculated as reported elsewhere.20,35 WMH, and lacunes were assessed according to the 
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9244 published criteria.12 The Wahlund scale (range 0-3) 37 was used to obtain the scores of  WMH of the 
245 frontal, parieto-occipital, and temporal areas (WMH-SC), infratentorial (WMH-INF), basal ganglia 
246 (WMH-BG),  and  the WMH total score (WMH-T). To define the WMH status, a cut-off score ≥2 in at 
247 least one of the above regions was used. WMH-PV were evaluated with the Fazekas scale (range 0-3),38 
248 and a cut-off score ≥2 was used. Lacunes were assessed topographically according to the Wahlund 
249 regions used to score WMH, and categorized  as lacunes-SC,  lacunes-BG, lacunes-INF, and lacunes-T. A 
250 cut-off score ≥2 in at least one of the Wahlund regions was used to define the status of lacunes. Subjects  
251 having WMH and/or lacunes with a score ≥2 in at least one of the Wahlund scale topographical locations 
252 were categorized as SVD positive (SVD+), and those having WMH and/or lacunes with a score ≤1 were 
253 categorized as SVD negative (SVD-). 
254
255 Statistical Analysis  
256 Descriptive statistics (percentages, mean and SD, median and IQR) were used to summarise data. 
257 Continuous variables were compared between subjects ISNA- and ISNA+ by using one-way analysis of 
258 variance (ANOVA), and differences were tested with a post hoc F-test. Categorical variables were 
259 evaluated by contingency tables, and the hypotheses of independence were tested with  2 test. Logistic 
260 ridge regression models39 were used to evaluate for each MCI type the risk of having  ISNA covarying for 
261 age, sex, years of education, and the variables found significant in the univariate analysis. In general, 
262 ridge regression method is the most applied solution for addressing problems of multicollinearity.40 It 
263 implies adding a small positive constant (), i.e. the ridge parameter, to the main diagonal elements of the 
264 information matrix. The ridge parameter was selected using likelihood cross-validation.41 IMT, BCr, and 
265 LVBr values were scaled to work on percentage of increments.  All tests were two-tailed, and statistical 
266 significance was set at p ≤ 0.05.  Results are presented as odds ratios (ORs) with 95% confidence interval 
267 (95% CI). All analyses were performed using R statistical software (version 3.5.1; The R Foundation for 
268 Statistical Computing).    
269
270
271 RESULTS
272 The demographic characteristics of the MCI types are shown in Table 1.  In almost all MCI types, 
273 the majority of  subjects  were elderly followed by old, adult, and oldest-old individuals. The MCI types 
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274 single domain were more common among the adults, while those multiple domain were more common 
275 within the elderly, old, and oldest old participants. In each age class, the mean age didn’t vary 
276 significantly among the various MCI types.  Since  the oldest old subjects were few, subsequent  analysis 
277 was conducted pooling the old and oldest old classes in the class of old-oldest old.  
278 Within the sample, 175 (14.0%) subjects didn’t show any of the selected  ISNA, while 1,075 
279 (86.0%) presented at least one ISNA (Table 2). Overall, subjects ISNA- were more common among the 
280 MCI types single domain, and subjects ISNA+ were more common among those multiple domain. 
281 Primitive reflexes were the most frequent ISNA, followed by ISNA central-based, and  mild parkinsonian 
282 signs, while ISNA cerebellar-based were the rarest.  PR were exhibited by 864 subjects (69.1%) of the 
283 sample, and were more common among  the MCI types multiple domain than those single domain. In all 
284 MCI types, snout reflex was the most common PR followed by glabellar tap, and palmomental reflex, 
285 while grasping  and sucking reflexes were the rarest. Snout and palmomental reflexes were more common 
286 among the MCI types multiple domain than those single domain, while glabellar tap was more common 
287 among the amnestic MCI types than the nonamnestic types.  The mean number of PR was greater among 
288 the amnestic MCI types than the nonamnestic types. Central-based  signs were exhibited  by 645 subjects 
289 (51,6%) of the sample. Subjects with Cs were more common among the nonamnestic MCI types than the 
290 amnestic types. In all MCI types, reflex asymmetry was the most common Cs, followed by bilateral 
291 hyperreflexia, central facial weakness, mixed rigidity, slurred speech, and dysphagia. Reflex asymmetry, 
292 bilateral hyperreflexia, and central facial weakness were more common among the nonamnestic MCI 
293 types than the amnestic types, while the frequency of the other Cs didn’t vary among the 4 MCI types. 
294 The  mean number of Cs was greater among the nonamnestic MCI types than the amnestic types.  Mild 
295 Parkinsonian Signs were found in 46,2% (n=578) of the sample. In all MCI types, bradykinesia was the 
296 most common MPS, followed by gait/balance/axial dysfunction, and tremor, while rigidity was the rarest. 
297 Individual MPS were more common among the MCI types multiple domain than the MCI  single domain. 
298 The mean number of MPS  was greater in the former than in the latter. Cerebellar-based signs  were the 
299 rarest ISNA encountered. Dysmetria was the most common CLs, and the atactic type gait was the rarest. 
300 The frequency of dysmetria didn’t vary among the 4 MCI types, while the atactic type gait was more 
301 common among the a-MCImd  than the other MCI types. The mean number of CLs didn’t vary among the 
302 MCI types.  
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303 ISNA increased with age reaching a peak in the old-oldest old individuals (Table 3). Among the 
304 adults, 210 subjects (65,8%) were ISNA+, and 109 subjects (34,2%) were ISNA-. PR were the most 
305 frequent ISNA followed by Cs, MPS, and CLs categories. PR. Cs, and MPS were  more common among 
306 the MCI types multiple domain than those single domain, while CLs didn’t vary in the 4 MCI types. The 
307 mean number of ISNA was greater in the former than in the latter. Within the elderly, 405 subjects 
308 (88,4%) were ISNA+, and 53 subjects (11,6%) were ISNA-. The frequency of subjects ISNA+ didn’t 
309 vary among the 4 MCI types. PR were the most frequent ISNA followed by Cs, MPS, and CLs categories. 
310 PR were almost equally distributed in the 4 MCI types, MPS and CLs were more common among the 
311 MCI types multiple domain, and Cs were more common among the nonamnestic MCI types. The mean 
312 number of ISNA was greater  in the nonamnestic MCI types, than in the amnestic  types.  Among the old-
313 oldest old subjects, 461 individuals (97,5%) presented at least one ISNA, and 12 individuals only (2,5%) 
314 were ISNA-. CLs and MPS didn’t vary among the 4 MCI types. Cs were significantly more common 
315 among the nonamnestic MCI types, while PR were significantly more common among the amnestic MCI 
316 type. The mean number of ISNA was significantly greater in the na-MCImd type than in the other MCI 
317 types. The co-occurrence of  multiple ISNA increased with age in all MCI types. 
318 Baseline characteristics of MCI types ISNA+ and  ISNA- are shown in Table 4. In all MCI types, no 
319 difference was found in the distribution of female and male among the two ISNA groups. In all MCI 
320 types, the  mean age of female  was greater in subjects ISNA+ than in subjects ISNA-, while the mean 
321 age of male was greater in subjects ISNA+ than in subjects ISNA- in the a-MCI only. Level of education 
322 didn’t vary  among the ISNA groups in MCI types single domain and in a-MCImd type, while in the na-
323 MCImd type subjects ISNA+ were less educated  than subjects ISNA-. The ADL scores were worse in 
324 the MCI types single domain ISNA+ only, and the IADL scores were worse in the MCI types single 
325 domain and a-MCImd ISNA+. In the na-MCImd type, ADL and IADL scores didn’t vary  among the two 
326 ISNA groups. Out of the VRF evaluated, arterial hypertension only was significantly more common 
327 among subjects ISNA+ than subjects ISNA- with the na-MCImd type, while no difference was found in 
328 the distribution of VRF among the two ISNA groups of the other MCI types. However, in a-MCI and na-
329 MCImd, the VRF summary score was greater in subjects ISNA+ than those ISNA-. No difference was 
330 found in the frequency of the VD evaluated among subjects ISNA+ and ISNA- of almost all MCI types, 
331 with the exception of history of TIA that was significantly more common among the subjects a-MCI 
332 ISNA+. The VD summary score  was greater in subjects ISNA+ than in those ISNA- in the  a-MCI only. 
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333 In the a-MCI type, APOE ε4 carriers were significantly more common in subjects ISNA+ than in subjects 
334 ISNA-, and APOE ε4 non carriers were significantly more common in subjects ISNA- than in subjects 
335 ISNA+. The distribution of APOE ε4 carriers and non carriers didn’t differ in the two ISNA groups of the 
336 other MCI types. 
337 Neuropsychological performances of MCI types ISNA+ and ISNA- are summarized in Table 5. The 
338 MMSE score was above the cut-off level in all MCI types, but subjects  a-MCI ISNA+ performed 
339 significantly less than subjects ISNA-. As expected, a worse performance on memory task was exhibited 
340 by the amnestic MCI types ISNA+ and ISNA-. In subjects with a-MCI, the nonmemory domains were not 
341 impaired, but subjects ISNA+ performed significantly less  than subjects ISNA- in attention, executive 
342 function, and language. In subjects a-MCImd ISNA+ and ISNA-, the nonmemory domains were 
343 impaired, and subjects ISNA+ performed significantly worse than subjects ISNA- in tests evaluating 
344 language. In the nonamnestic MCI types no significant difference was found in the performance of 
345 nonmemory domains among subjects ISNA+ and ISNA-, although a trend of worse performance of 
346 subjects ISNA+ in almost all cognitive domains  was evident.
347 Carotid ultrasonography and imaging findings in the MCI types ISNA+ and ISNA-  are reported in 
348 Table 6.  In all MCI types, the frequency of  IMT  was  significantly higher in subjects ISNA+ than 
349 subjects ISNA-, while the frequency of SICA didn’t differ between the two ISNA groups. In a-MCI, na-
350 MCI, and na-MCImd, WMH-SC, WMH-T, and WMH-PV were  significantly higher in subjects ISNA+ 
351 than subjects ISNA-, while in a-MCImd WMH-BG only were significantly higher in subjects ISNA+. 
352 Lacunes-BG and lacunes-T were significantly higher in MCI types single domain ISNA+,  and lacunes-T 
353 were significantly higher in na-MCImd ISNA+. In a-MCI, na-MCI, and na-MCImd, SVD+ was more 
354 common in subjects ISNA+ than ISNA-, while SVD- was more common among the subjects ISNA- than 
355 ISNA+. In a-MCImd,  the distribution of subjects SVD+ and SVD- didn’t differ among the two ISNA 
356 groups. BCr was significantly higher in all MCI types ISNA+ with the exception of a-MCImd type. LVBr 
357 was significantly higher in the MCI types single domain ISNA+, while no difference among the ISNA 
358 groups was found  in the MCI types multiple domains. 
359  To assess the effects of  the variables evaluated on the estimated probability of having at least one 
360 ISNA, logistic ridge regression analysis was carried out in each MCI type (Table 7). Age resulted 
361 associated with a-MCI type only. For each year of age increase, the odds of  having at least one ISNA 
362 went up about 3%. Being female increased by 7,7% the probability of having at least one ISNA in the a-
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363 MCI type only. Education, and VRF summary score didn’t influence the probability of having at least one 
364 ISNA in any of the MCI types. VD summary score increased the probability of having at least one ISNA 
365 in a-MCI (18,1%), na-MCI (11,1%), and na-MCImd (4,5%). Being carrier of the APOE ε4 allele 
366 increased by 52,7%,  16,5%, and 5,1%  the probability of having at least one ISNA in  a-MCI, a-MCImd, 
367 and na-MCImd, respectively. At the increase of a single percentage point of the IMT the probability of 
368 having at least one ISNA  in a-MCI, a-MCImd, na-MCI, and na-MCImd went up  by  52,7%, 36,9%, 
369 14,8%, and 16,3%, respectively.  The presence of WMH-PV increased by 36,7%, 58,4%, and 14,3% the 
370 probability of having at least one ISNA  in  a-MCI, na-MCI, and  na-MCImd, respectively. The presence 
371 of SVD in the frontal region increased the risk of having at least one ISNA  in a-MCI (16,4%), na-MCI 
372 (54,5%), and na-MCImd (16%) types. The presence of SVD in the parieto-occipital region  increased the 
373 risk of having at least one ISNA   in a-MCI, na-MCI, and na-MCImd by 22,3%, 30,3%, and 10,5%, 
374 respectively.  The presence of SVD in the lateral temporal region increased the risk of having at least one 
375 ISNA in a-MCI, a-MCImd, na-MCI, and na-MCImd MCI  by 14,0%, 15,9%, 19,8%, and 8,4%, 
376 respectively. The presence of SVD in the basal ganglia increased the risk of having at least one ISNA in 
377 a-MCI, a-MCImd, na-MCI, and na-MCImd by 29,9%, 31,1%, 51,8%, and 9,7%, respectively. BCr, and 
378 LVBr resulted associated with all the MCI types.  At the increment of a single percentage point of  BCr, 
379 the probability of having at least one ISNA  increased by 15,6% in a-MCI, 31,9% in a-MCImd, 65,8% in 
380 na-MCI, and 32,4% in na-MCImd.  At the increment of a single percentage point of LVBr, the odds of 
381 having at least one ISNA  increased by 13,1% in a-MCI, 6,2% in a-MCImd, 9,6% in na-MCI, and 5,2% in 
382 na-MCImd. 
383
384
385 DISCUSSION
386           The frequency of ISNA detected in subjects with MCI was greater (86%) than that found in NCH 
387 aging individuals (57,2%).20 In all MCI types, and in all age classes, PR were the ISNA most frequently 
388 encountered, followed by Cs, MPS, and CLs. All ISNA categories increased with age, and were presented 
389 by both the amnestic and nonamnestic MCI types, particularly by those  multiple domain, with the 
390 exception of Cs and PR that in the old-oldest old subjects were more common among the MCI types 
391 single domain. 
392           Copious data of the literature underline  the importance of midlife vascular risks and Aβ burden to 
393 neurodegenerative processes, and to the development of cognitive decline in older adults. In CN 
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394 individuals,  midlife VRF accelerate structural brain aging,42 are associated with greater  prospective 
395 cognitive decline,43 current and later-life smaller brain volumes,44 and risk of dementia.45 Further, midlife 
396 but not later-life exposure to VRF is important also for Aβ deposition, as shown by the fact that having 2 
397 or more midlife VRF compared with none is significantly associated with elevated Aβ deposition (61.2% 
398 vs 30.8%).46 In addition, in CN and  MCI  individuals, VRF  interact with Aβ to reduce cortical thickness 
399 in frontotemporal and parietal regions vulnerable to AD,47 and are associated with prospective cognitive 
400 decline, both alone and synergistically with Aβ burden.48 However, VRF summary score was not 
401 associated with ISNA in any of the 4 MCI types, and VD summary score increased the probability of 
402 having at least one ISNA in the MCI types single domain, and poorly in the na-MCImd. These data need 
403 attention. A high vascular risk burden at younger ages is indeed indicative of early vascular aging,49 but in 
404 the later years of life it is less relevant regarding the MCI typology since vascular and neurodegenerative 
405 processes have already occurred at younger ages when the MCI typology is likely to be of single domain 
406 type. The fact that subjects with MCI types multiple domain were older than subjects with MCI types 
407 single domain supports this hypothesis.  IMT increased the probability of  having at least one  ISNA in all 
408 MCI types, and the risk was greater for the amnestic MCI types than for the nonamnestic types.  These 
409 results are in agreement with a previous study showing that IMT is associated with WMH, infarcts, brain 
410 atrophy, and with poor cognitive performance particularly in the executive function.50 Further, IMT 
411 significantly increases the risk of conversion of a-MCI to dementia.51 WMH-PV increased greatly the 
412 probability of having at least one ISNA in MCI types single domain, and in the na-MCImd.  It has been 
413 shown that WMH-PV are associated with elevated Aβ deposition independently from age and presence of 
414 APOE ε4 allele,52 and  induce thinning of prefrontal, parietal, temporal cortices, anterior insula, and 
415 atrophy of the caudate nuclei,14 and cognitive decline through the cortical atrophy of the above 
416 disconnected regions.19 Therefore, it is reasonable  to suspect that  even in our MCI types WMH-PV may 
417 also have induced atrophy of the caudate nuclei, and thinning of  the frontal, parietal, and temporal 
418 cortices through likely disruption of periventricular long associating tracts.  
419           Overall, SVD at different topographical locations, and BCr greatly increases the risk of having  
420 ISNA in all the MCI types. Given that cortex, cerebellum, and BG are strictly interconnected,53  it is 
421 likely that ISNA are the by-product of the disconnection of the cortical-cerebellar-basal ganglia-thalamo-
422 cortical circuits induced by vascular and degenerative processes. It is also likely that the caudate atrophy 
423 and  the disruption of the internal circuits of  BG may have induced  an excessive inhibition to its output 
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424 nuclei. As a consequence, the inhibitory drive to thalamus  may have led to bradykinesia, and that to 
425 brainstem structures controlling postural muscle tone and locomotion may have led to rigidity and 
426 gait/balance/axial dysfunction respectively,54 while the inhibition of the physiological inhibitor control of 
427 lower brainstem centres on stereotyped motor responses55 may have led to the reappearance of  PR.    
428           Nevertheless, the above hypotheses underpinning the vascular contribution to ISNA do not fully 
429 explain their presentation in the various MCI types.  Among the amnestic MCI types,  39% (n=342) of 
430 subjects ISNA+ were SVD-, and 5% (n=45) of  subjects ISNA- were SVD+. Similarly, among the 
431 nonamnestic MCI types 51% (n=190) of subjects ISNA+ were SVD-, and 35% (n=130) of  subjects 
432 ISNA- were SVD+. These conflicting data suggest that co-occurring factors others than vascular 
433 contribute to the presentation of  ISNA. The APOE ε4 allele can be one of these factors.  In the present 
434 study, the APOE ε4 carriers were indeed over-represented relative to other studies, probably because the 
435 CogItA study  assessed essentially subjects referred to the memory clinic, making the sample vulnerable 
436 to selection. Overall, APOE ε4 carriers were more common among subjects ISNA+ than subjects ISNA- 
437 in all MCI types, and  being ε4 carrier increased the probability of having at least one ISNA greatly in the 
438 amnestic MCI types and scarcely in the nonamnestic MCI types, a finding in agreement with the notion 
439 that compared to non ε4 carriers, MCI ε4 carriers have frequently the amnestic phenotype.56 The presence 
440 of APOE ε4 allele in nonamnestic MCI types is not surprising. Along with age, APOE ε4 allele is a 
441 significant predictor of  amyloidosis. More than half of all MCI types is Aβ positive,57 and  APOE ε4 
442 carriers are 2-3 times more likely to be amyloid positive than APOE ε4 non carriers.6 Subjects with MCI 
443 have elevated Aβ deposition  in frontal, parietal, temporal, and posterior cingulate cortices suggestive of 
444 early AD process,58 and those converting to AD  have a greater Aβ deposition in these regions, as well as 
445 in the putamen and in the caudate nuclei  as compared to nonconverters.59   Furthermore, in subjects with 
446 MCI the presence of the APOE ε4 allele is more frequent in the converters than in the nonconverters.60 
447 Therefore, it is reasonable to suspect that subjects of all 4 MCI types carrying the APOE ε4 allele were 
448 also Aβ positive, and that subjects ISNA+ being more APOE ε4 carriers than subjects ISNA- were 
449 candidates to convert  to dementia faster than subjects ISNA-.
450
451 Limitations of the study
452           Some limitations of  our study are worth noting. First, CSF biomarkers of Aβ and tau, and 
453 advanced imaging techniques up to now are not fully available in our country, particularly  in a clinical 
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454 setting. So, we do not know the distribution of Aβ and tau  in subjects ISNA+ and ISNA- of the various 
455 MCI types. Second, we assessed cortical and subcortical atrophy using linear measurements well aware 
456 that  they are rather crude estimates of brain atrophy. However, it has been shown that the bicaudate ratio 
457 is a reliable marker of caudate atrophy,61 and that ventricular enlargement is a feasible, even if 
458 nonspecific, surrogate marker of neurodegeneration in MCI and AD.16 Third, we didn’t estimate WMH 
459 volumetrically, but visually. However, it has been shown that WMH evaluated with visual scales correlate 
460 well with WMH volumetry.62  Fourth, perhaps we underestimated the magnitude of cerebral SVD in our 
461 cohort, because we evaluated WMH and lacunes only.  Fifth, the generalizability of our results is limited 
462 because the patients have been selected in a hospital setting. Sixth, in the present paper there is not 
463 mention of  the ISNA in neurologically and cognitively normal subjects because data on this topic 
464 has been already published.20 Lastly, the cross-sectional design of our study doesn’t allow causal 
465 inferences. 
466
467 CONCLUSION 
468           ISNA are likely to have a multifactorial origin, increase with age, and are presented by both the 
469 amnestic and nonamnestic MCI types, particularly by those multiple domain, and carrying the APOE ε4 
470 allele. Further, subjects ISNA+ perform less than subjects ISNA- in almost all nonmemory domains. 
471 Given that cortical and subcortical vascular and  atrophic processes contribute to ISNA, their presence in 
472 individuals with MCI must alert the practitioners to target timely interventions to slowing cognitive 
473 decline and delay progression of MCI to dementia. Longer prospective population-based studies are 
474 needed to clarify to what extent the presentation of ISNA  in middle-aged and older MCI individuals 
475 represents  an additive risk  for  the conversion to dementia.
476
477
478
479
480
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